Richard E. Kaufman
Keine laufenden Positionen mehr
Karriereverlauf von Richard E. Kaufman
Ehemalige bekannte Positionen von Richard E. Kaufman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INTERSECT ENT, INC. | Geschäftsführer | 01.01.2007 | 29.10.2018 |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 | 29.10.2018 | |
| McGhan Medical SARL | Corporate Officer/Principal | - | - |
| Guidant Vascular Intervention | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
Ausbildung von Richard E. Kaufman
| Arizona State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Frankreich | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 2 |
| Health Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Intersect ENT, Inc.
 Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. | Health Services |
| Guidant Vascular Intervention | |
| McGhan Medical SARL | Distribution Services |
- Börse
- Insiders
- Richard E. Kaufman
- Erfahrung
